Scientists hunt for testicular cancer genes in families
NCT ID NCT00034424
First seen Jun 27, 2026 · Last updated Sep 17, 2026 · Updated 12 times
Summary
This study aims to understand why testicular cancer sometimes runs in families. Researchers will collect DNA samples and medical information from about 750 people in families with multiple cases of testicular cancer. No treatment is given; the goal is to find genes that increase risk and learn more about the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
749 people
The number who actually took part.
- Started
-
Jan 2003
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
A non-randomized cohort study of individuals from families with a significant history of testicular cancer.
- Ages
-
12 to 77 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA: Study population: Patients must be members of families with familial TGCT as defined below. Definition of familial TGCT: The criterion establishing familial TGCT is the presence of: -at least two cases of documented GCT in blood relatives (at least one of which is testicular in origin), OR * a single family member with bilateral testicular cancer, * men with a history of TGCT who are one in a set of identical siblings will also be included in the study. Case definition: A case will be determined to have TGCT according to the following criteria: * Pathologic confirmation of a germ cell derived tumor arising in the testis. Extragonadal germ cell tumors will also be included. * Germ cell derived histologies including: seminoma, germinoma, embryonal carcinoma, endodermal sinus (yolk sac) tumor, gonadoblastoma, choriocarcinoma, teratoma, and mixed germ cell tumor. * A case will be determined to have TIN on the basis of pathologic confirmation of intratubular malignant germ cells (ITMGCs) as defined by Burke and Mostofi. Individuals from participating families who are eligible for this study include: i) all TGCT cases; ii) all GCT cases (including those of ovarian or extra-gonadal sites); iii) all first-degree relatives of each GCT case; iv) the spouse(s) of every case if the spouse and case had children who are participating in the study; v) any blood relative not included in (ii - iii) above who genetically links two cases; and vi) any blood relative with cancer other than GCT vii) family members as described in i) - v) above must be age 12 or greater in order to participate EXCLUSION CRITERIA: Families will be deemed ineligible for participation in this study if: There are not at least two confirmed cases of GCT in the family, (at least one of which is testicular in origin), unless there is a family member with bilateral testicular cancer; Deceased TGCT cases lacking both archival sources of tissue for DNA extraction AND lacking surviving spouses and children who are willing to participate in the study (the unavailability of such persons prohibits inferring the genotype of the deceased individual with TGCT); Critical informative family members are unwilling to participate (i.e., unwilling to provide written informed consent);
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Extragonadal germ cell tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cancer diagnosis can shock the whole family: study maps who struggles most
- Can a faster chemo schedule beat tough testicular cancer?
- Hidden heart risks in testicular cancer survivors: a closer look at chemotherapy's long shadow
- Glowing dye could reveal hidden cancer spread in testicular tumors
- New chemo cocktail targets Hard-to-Treat testicular cancer
- High-Dose chemo with stem cell transplant tested against standard therapy for tough germ cell cancers